Farms.com Home   News

Pulse Processors Now In Receivership

The Canadian Grain Commission confirming that CanPulse Foods out of Kindersley, Global Grain at Plum Coulee, and Globeways Canada have been placed into receivership.
 
Remi Gosselin with the Canadian Grain Commission says the three companies went into receivership November 19th.
 
"The CGC holds security in the form of a payable insurance policy in the amounts of $6.5 million for Canpulse Foods Limited, $1.25 million for Global Grain Canada Limited and $50,000 for Globeways Canada Incorporated."
 
Gosselin says they are aware that some producers recently demanded the return of their grain from Global Grain at Plum Coulee for unpaid deliveries.
 
"This is the first time in recent memory that producers have exercised their right to the return of grain of this magnitude. So, we believe that the company has returned the majority of this inventory to producers that hold outstanding elevator receipts. We consider it to be a good news story and it also serves to reduce liability to producers.
 
Gosselin reminds producers that are still owed money that they must file a claim with the Canadian Grain Commission by November 30th, after which time claims will be evaluated.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.